Edgewise Therapeutics Inc (EWTX)
26.09
+0.10
(+0.38%)
USD |
NASDAQ |
Sep 27, 16:00
26.06
-0.03
(-0.11%)
After-Hours: 20:00
Edgewise Therapeutics Accounts Payable (Quarterly): 6.801M for June 30, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 6.801M |
March 31, 2024 | 4.723M |
December 31, 2023 | 4.025M |
September 30, 2023 | 5.318M |
June 30, 2023 | 3.781M |
March 31, 2023 | 3.875M |
December 31, 2022 | 6.105M |
September 30, 2022 | 5.757M |
Date | Value |
---|---|
June 30, 2022 | 2.828M |
March 31, 2022 | 5.34M |
December 31, 2021 | 3.843M |
September 30, 2021 | 2.292M |
June 30, 2021 | 2.816M |
March 31, 2021 | 1.621M |
December 31, 2020 | 1.58M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.58M
Minimum
Dec 2020
6.801M
Maximum
Jun 2024
4.047M
Average
3.875M
Median
Mar 2023
Accounts Payable (Quarterly) Benchmarks
Catalyst Pharmaceuticals Inc | 7.116M |
Cytokinetics Inc | 9.47M |
Vanda Pharmaceuticals Inc | 2.266M |
Vertex Pharmaceuticals Inc | 327.90M |
Sarepta Therapeutics Inc | 107.42M |